84 results
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties … U.S. Treasury securities with insignificant rates of return, or may hold such proceeds as cash, until they are used for their stated purpose. We have
8-K
EX-1.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
the effectiveness of the Registration Statement is in effect, and no proceedings for such purpose or pursuant to Section 8A under the Securities Act are pending … , (2) licensed for the purpose of making derivative works or (3) redistributed at no charge.
Except as described in each of the Registration Statement
8-K
EX-4.1
np4vzj y8n3ara
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
424B5
glcj0du wbzqyf
16 Apr 24
Prospectus supplement for primary offering
5:21pm
S-8
0cbgu8qh42wny56d
6 Mar 24
Registration of securities for employees
4:05pm
S-8
31v d3fxq
16 Jun 23
Registration of securities for employees
4:38pm
8-K
EX-4.1
rzn6f4
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-1.1
nzhj g35zy3drbxdcnpm
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am